Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H GROOT

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Atherosclerosis|November 1, 1994
Diet-induced hypercholesterolemia and atherosclerosis in heterozygous apolipoprotein E-deficient miceJ H van Ree, W J van den Broek, V E Dahlmans, et al.
JAMA Network Open|February 23, 2023
Association of Proton Pump Inhibitor Use With Risk of Acquiring Drug-Resistant EnterobacteralesRoel P J Willems, Martijn C Schut, Anna M Kaiser, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 2, 1998
Identification of a truncated form of the CC chemokine CK beta-8 demonstrating greatly enhanced biological activityC H Macphee, E R Appelbaum, K Johanson, et al.
Journal of Medicinal Chemistry|August 30, 1996
ATP-citrate lyase as a target for hypolipidemic intervention. Design and synthesis of 2-substituted butanedioic acids as novel, potent inhibitors of the enzymeA D Gribble, R E Dolle, A Shaw, et al.
Journal of Medicinal Chemistry|September 11, 1998
ATP-Citrate lyase as a target for hypolipidemic intervention. 2. Synthesis and evaluation of (3R,5S)-omega-substituted-3-carboxy-3, 5-dihydroxyalkanoic acids and their gamma-lactone prodrugs as inhibitors of the enzyme in vitro and in vivoA D Gribble, R J Ife, A Shaw, et al.
The Journal of Biological Chemistry|June 27, 1997
Cloning, in vitro expression, and functional characterization of a novel human CC chemokine of the monocyte chemotactic protein (MCP) family (MCP-4) that binds and signals through the CC chemokine receptor 2BT A Berkhout, H M Sarau, K Moores, et al.
Nature Genetics|June 5, 2019
Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesityValérie Turcot, Yingchang Lu, Heather M Highland, et al.
Nature Genetics|December 24, 2017
Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesityValérie Turcot, Yingchang Lu, Heather M Highland, et al.
Nature Genetics|March 18, 2018
Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesityValérie Turcot, Yingchang Lu, Heather M Highland, et al.
Nature Genetics|March 18, 2018
Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesityValérie Turcot, Yingchang Lu, Heather M Highland, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Atherosclerosis|November 1, 1994
Diet-induced hypercholesterolemia and atherosclerosis in heterozygous apolipoprotein E-deficient miceJ H van Ree, W J van den Broek, V E Dahlmans, et al.
JAMA Network Open|February 23, 2023
Association of Proton Pump Inhibitor Use With Risk of Acquiring Drug-Resistant EnterobacteralesRoel P J Willems, Martijn C Schut, Anna M Kaiser, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 2, 1998
Identification of a truncated form of the CC chemokine CK beta-8 demonstrating greatly enhanced biological activityC H Macphee, E R Appelbaum, K Johanson, et al.
Journal of Medicinal Chemistry|August 30, 1996
ATP-citrate lyase as a target for hypolipidemic intervention. Design and synthesis of 2-substituted butanedioic acids as novel, potent inhibitors of the enzymeA D Gribble, R E Dolle, A Shaw, et al.
Journal of Medicinal Chemistry|September 11, 1998
ATP-Citrate lyase as a target for hypolipidemic intervention. 2. Synthesis and evaluation of (3R,5S)-omega-substituted-3-carboxy-3, 5-dihydroxyalkanoic acids and their gamma-lactone prodrugs as inhibitors of the enzyme in vitro and in vivoA D Gribble, R J Ife, A Shaw, et al.
The Journal of Biological Chemistry|June 27, 1997
Cloning, in vitro expression, and functional characterization of a novel human CC chemokine of the monocyte chemotactic protein (MCP) family (MCP-4) that binds and signals through the CC chemokine receptor 2BT A Berkhout, H M Sarau, K Moores, et al.
Nature Genetics|June 5, 2019
Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesityValérie Turcot, Yingchang Lu, Heather M Highland, et al.
Nature Genetics|December 24, 2017
Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesityValérie Turcot, Yingchang Lu, Heather M Highland, et al.
Nature Genetics|March 18, 2018
Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesityValérie Turcot, Yingchang Lu, Heather M Highland, et al.
Nature Genetics|March 18, 2018
Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesityValérie Turcot, Yingchang Lu, Heather M Highland, et al.
Pageof 8